Search Results 781-790 of 21126 for Informed consent

1. Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry - Mayo Clinic

   Subject is ≥ 18 years of age at the time of consent and is willing to sign an informed consent document approved by the enrolling hospital's Institutional ...

2. Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) - Mayo Clinic

   Able to sign an informed consent. Exclusion Criteria: Diagnostic of cholangiocarcinoma made more than 45 days prior to randomization; Cholangiocarcinoma with ...

3. A Study Of The ExAblate UF V2 System For The Treatment Of Symptomatic Uterine Fibroids - Mayo Clinic

   Patients who have given written informed consent; Patients who are able and willing to attend all study visits; Patients who are pre or peri-menopausal ...

4. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

   - Ability to provide written informed consent prior to initiation of any trial-specific procedures, and ability, in the opinion of the principal ...

5. A Study to Evaluate Umbilical Cord Tissue as a Source of Therapeutic Cells - Mayo Clinic

   Can provide written informed consent and complete HIPAA documentation after the nature of the study is fully explained and prior to any study-related procedure.

6. A Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Terlipressin Treatment - Mayo Clinic

   Contact the study team to discuss study eligibility and potential participation. Show more eligibility criteria. Inclusion Criteria. Written informed consent by ...

7. Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation - Mayo Clinic

   ... informed consent. Exclusion Criteria: Mitral valvular vegetation or mass. Left Ventricle (LV) or Left Atrium (LA) thrombus. Chest condition that prevents ...

8. Prevention Of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) - Mayo Clinic

   Subject able to provide written informed consent; Subject must be willing and able to comply with the requirements of the study protocol; Female subjects of ...

9. Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma - Mayo Clinic

   Signed informed consent including, where applicable, the consent of the patient's legal guardian. Exclusion Criteria: Current extrapulmonary disease ...

10. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

    Male and female adult patients (≥ 18 years of age on day of signing informed consent) with a histologically confirmed advanced, metastatic, or progressive ...